Beta Bionics, Inc. Increase (Decrease) in Inventories
Beta Bionics, Inc. (BBNX) reported Increase (Decrease) in Inventories of $2.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-29
- Beta Bionics, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $214.00K, a 87.62% decline year-over-year.
- Beta Bionics, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $1.80M, a 31.21% decline year-over-year.
- Beta Bionics, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $2.20M, a 82.22% increase year-over-year.
- Beta Bionics, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $3.33M, a 15.32% decline year-over-year.
- Beta Bionics, Inc. increase (decrease) in inventories for fiscal 2025 was $9.88M, a 13.63% decline from fiscal 2024.
- Beta Bionics, Inc. increase (decrease) in inventories for fiscal 2024 was $11.44M, a 863.69% increase from fiscal 2023.
- Beta Bionics, Inc. increase (decrease) in inventories for fiscal 2023 was $1.19M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $2.02M 10-Q · filed 2026-07-29 | $4.22M derived: sum of 3 quarters · filed 2026-07-29 | $7.55M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $1.80M 10-Q · filed 2026-04-21 | $4.01M derived: sum of 2 quarters · filed 2026-04-21 | $7.33M derived: sum of 3 quarters · filed 2026-04-21 | $9.06M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.53M derived: sum of 2 quarters · filed 2026-02-24 | $7.26M derived: sum of 3 quarters · filed 2026-07-29 | $9.88M 10-K · filed 2026-02-24 |
| 2025-09-30 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $5.06M derived: sum of 2 quarters · filed 2026-07-29 | $7.68M 10-Q · filed 2025-10-28 | $8.89M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $4.35M 10-Q · filed 2026-07-29 | $5.56M derived: sum of 3 quarters · filed 2026-07-29 | $9.49M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $2.62M 10-Q · filed 2026-04-21 | $3.83M derived: sum of 2 quarters · filed 2026-04-21 | $7.76M derived: sum of 3 quarters · filed 2026-04-21 | $11.65M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.14M derived: sum of 2 quarters · filed 2026-02-24 | $9.03M derived: sum of 3 quarters · filed 2026-02-24 | $11.44M 10-K · filed 2026-02-24 |
| 2024-09-30 | $3.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $7.82M derived: sum of 2 quarters · filed 2025-10-28 | $10.23M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $3.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $6.30M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $2.41M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $1.19M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |